Anacor Pharmaceuticals, Inc. · Palo Alto, CA United States (NASDAQ: ANAC)
| 1020 E. Meadow Cir. | Phone: 650-543-7500 |
| Palo Alto, CA | Fax: 650-543-7660 |
| 94303 | |
| United States | 
Map This Company |
Anacor Pharmaceuticals, Inc. Rankings
| Russell 2000 (June 2011) |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Anacor is hardcore about curing skin conditions. The company is developing boron-based drug compounds for use as topical treatments of bacterial, fungal, and inflammatory conditions. Its lead candidates aim to treat onychomycosis (a kind of toenail fungus), psoriasis, and hospital-acquired bacterial infections. Anacor has focused on topical treatments for the time being because they are relatively easy to develop and market, but it believes its boron chemistry can produce drugs in therapeutic fields such as viral and parasitic infections and and rare infectious diseases. The company filed to go public in 2010.
Anacor Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ANAC Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 80 |
Executives
33 executives listed for Anacor Pharmaceuticals, Inc.'s Palo Alto, CA location.
| Chairman | Mark Leschly | |
|---|---|---|
| President, CEO, and Director | David Perry | |
| SVP and CFO | Geoffrey Parker |